SUPN logo

Supernus Pharmaceuticals, Inc. (SUPN) Net Income

Annual Net Income:

$73.86M+$72.55M(+5512.84%)
December 31, 2024

Summary

  • As of today, SUPN annual net profit is $73.86 million, with the most recent change of +$72.55 million (+5512.84%) on December 31, 2024.
  • During the last 3 years, SUPN annual net income has risen by +$20.44 million (+38.26%).
  • SUPN annual net income is now -41.82% below its all-time high of $126.95 million, reached on December 31, 2020.

Performance

SUPN Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNincome statement metrics

Quarterly Net Income:

$22.50M+$34.33M(+290.23%)
June 30, 2025

Summary

  • As of today, SUPN quarterly net profit is $22.50 million, with the most recent change of +$34.33 million (+290.23%) on June 30, 2025.
  • Over the past year, SUPN quarterly net income has increased by +$2.58 million (+12.97%).
  • SUPN quarterly net income is now -72.55% below its all-time high of $81.97 million, reached on December 31, 2011.

Performance

SUPN Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNincome statement metrics

TTM Net Income:

$64.50M+$2.58M(+4.17%)
June 30, 2025

Summary

  • As of today, SUPN TTM net profit is $64.50 million, with the most recent change of +$2.58 million (+4.17%) on June 30, 2025.
  • Over the past year, SUPN TTM net income has increased by +$59.26 million (+1131.09%).
  • SUPN TTM net income is now -50.12% below its all-time high of $129.31 million, reached on September 30, 2020.

Performance

SUPN TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNincome statement metrics

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

SUPN Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+5512.8%+13.0%+1131.1%
3Y3 Years+38.3%+186.1%+12.2%
5Y5 Years-34.7%-35.1%-50.1%

SUPN Net Income Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+5512.8%-41.6%+240.8%-12.7%+515.9%
5Y5-Year-41.8%+5512.8%-43.8%+240.8%-50.1%+515.9%
All-TimeAll-Time-41.8%+180.1%-72.5%+182.2%-50.1%+169.9%

SUPN Net Income History

DateAnnualQuarterlyTTM
Jun 2025
-
$22.50M(+290.2%)
$64.50M(+4.2%)
Mar 2025
-
-$11.83M(-177.2%)
$61.91M(-16.2%)
Dec 2024
$73.86M(+5512.8%)
$15.33M(-60.2%)
$73.86M(+23.7%)
Sep 2024
-
$38.50M(+93.3%)
$59.71M(+1039.8%)
Jun 2024
-
$19.92M(>+9900.0%)
$5.24M(+133.8%)
Mar 2024
-
$124.00K(-89.4%)
-$15.51M(-1278.4%)
Dec 2023
$1.32M(-97.8%)
$1.18M(+107.4%)
$1.32M(-94.9%)
Sep 2023
-
-$15.98M(-1822.5%)
$25.62M(-40.9%)
Jun 2023
-
-$831.00K(-104.9%)
$43.35M(-16.7%)
Mar 2023
-
$16.95M(-33.5%)
$52.04M(-14.3%)
Dec 2022
$60.71M(+13.6%)
$25.48M(+1356.9%)
$60.71M(+61.2%)
Sep 2022
-
$1.75M(-77.8%)
$37.67M(-34.5%)
Jun 2022
-
$7.87M(-69.3%)
$57.48M(-21.6%)
Mar 2022
-
$25.62M(+949.0%)
$73.35M(+37.3%)
Dec 2021
$53.42M(-57.9%)
$2.44M(-88.7%)
$53.42M(-34.6%)
Sep 2021
-
$21.56M(-9.1%)
$81.75M(-18.4%)
Jun 2021
-
$23.73M(+316.7%)
$100.19M(-9.8%)
Mar 2021
-
$5.69M(-81.5%)
$111.13M(-12.5%)
Dec 2020
$126.95M(+12.3%)
$30.77M(-23.1%)
$126.95M(-1.8%)
Sep 2020
-
$40.00M(+15.4%)
$129.31M(+9.4%)
Jun 2020
-
$34.67M(+61.1%)
$118.17M(+1.7%)
Mar 2020
-
$21.52M(-35.0%)
$116.23M(+2.8%)
Dec 2019
$113.06M(+1.9%)
$33.13M(+14.8%)
$113.06M(+6.8%)
Sep 2019
-
$28.86M(-11.8%)
$105.82M(+0.8%)
Jun 2019
-
$32.73M(+78.4%)
$104.97M(+1.9%)
Mar 2019
-
$18.34M(-29.2%)
$102.98M(-7.2%)
Dec 2018
$110.99M(+93.8%)
$25.89M(-7.6%)
$110.99M(+12.4%)
Sep 2018
-
$28.01M(-8.9%)
$98.76M(+13.9%)
Jun 2018
-
$30.74M(+16.6%)
$86.71M(+18.2%)
Mar 2018
-
$26.35M(+92.9%)
$73.34M(+28.0%)
Dec 2017
$57.28M
$13.66M(-14.4%)
$57.28M(-1.1%)
DateAnnualQuarterlyTTM
Sep 2017
-
$15.96M(-8.1%)
$57.95M(-44.2%)
Jun 2017
-
$17.37M(+68.7%)
$103.81M(+7.4%)
Mar 2017
-
$10.30M(-28.1%)
$96.69M(+6.0%)
Dec 2016
$91.22M(+554.2%)
$14.32M(-76.8%)
$91.22M(+8.9%)
Sep 2016
-
$61.83M(+503.1%)
$83.75M(+220.3%)
Jun 2016
-
$10.25M(+112.5%)
$26.15M(+42.6%)
Mar 2016
-
$4.83M(-29.6%)
$18.34M(+28.7%)
Dec 2015
$13.94M(-29.8%)
$6.85M(+62.3%)
$14.25M(+21.3%)
Sep 2015
-
$4.22M(+73.2%)
$11.75M(-66.8%)
Jun 2015
-
$2.44M(+230.2%)
$35.39M(-2.1%)
Mar 2015
-
$738.00K(-83.1%)
$36.15M(+81.9%)
Dec 2014
$19.87M(+121.5%)
$4.35M(-84.4%)
$19.87M(+388.4%)
Sep 2014
-
$27.86M(+770.0%)
-$6.89M(+88.3%)
Jun 2014
-
$3.20M(+120.6%)
-$58.84M(+34.2%)
Mar 2014
-
-$15.54M(+30.6%)
-$89.40M(+3.1%)
Dec 2013
-$92.27M(-99.4%)
-$22.41M(+7.0%)
-$92.27M(-10.7%)
Sep 2013
-
-$24.10M(+11.9%)
-$83.38M(-14.6%)
Jun 2013
-
-$27.36M(-48.6%)
-$72.77M(-31.3%)
Mar 2013
-
-$18.41M(-36.3%)
-$55.42M(-19.7%)
Dec 2012
-$46.28M(-99.3%)
-$13.51M(-0.2%)
-$46.28M(-194.1%)
Sep 2012
-
-$13.48M(-34.6%)
$49.20M(-7.1%)
Jun 2012
-
-$10.01M(-7.9%)
$52.95M(-4.7%)
Mar 2012
-
-$9.28M(-111.3%)
$55.59M(+3.3%)
Dec 2011
-$23.23M(+40.6%)
$81.97M(+942.2%)
$53.81M(+246.5%)
Sep 2011
-
-$9.73M(-32.0%)
-$36.73M(-36.1%)
Jun 2011
-
-$7.38M(+33.2%)
-$27.00M(-37.6%)
Mar 2011
-
-$11.05M(-28.9%)
-$19.62M(-128.9%)
Dec 2010
-$39.08M(-1044.3%)
-$8.57M(-4.7%)
-$8.57M(-4.7%)
Dec 2009
$4.14M(+112.4%)
-$8.19M
-$8.19M
Dec 2008
-$33.48M(-93.8%)
-
-
Dec 2007
-$17.27M
-
-

FAQ

  • What is Supernus Pharmaceuticals, Inc. annual net profit?
  • What is the all-time high annual net income for Supernus Pharmaceuticals, Inc.?
  • What is Supernus Pharmaceuticals, Inc. annual net income year-on-year change?
  • What is Supernus Pharmaceuticals, Inc. quarterly net profit?
  • What is the all-time high quarterly net income for Supernus Pharmaceuticals, Inc.?
  • What is Supernus Pharmaceuticals, Inc. quarterly net income year-on-year change?
  • What is Supernus Pharmaceuticals, Inc. TTM net profit?
  • What is the all-time high TTM net income for Supernus Pharmaceuticals, Inc.?
  • What is Supernus Pharmaceuticals, Inc. TTM net income year-on-year change?

What is Supernus Pharmaceuticals, Inc. annual net profit?

The current annual net income of SUPN is $73.86M

What is the all-time high annual net income for Supernus Pharmaceuticals, Inc.?

Supernus Pharmaceuticals, Inc. all-time high annual net profit is $126.95M

What is Supernus Pharmaceuticals, Inc. annual net income year-on-year change?

Over the past year, SUPN annual net profit has changed by +$72.55M (+5512.84%)

What is Supernus Pharmaceuticals, Inc. quarterly net profit?

The current quarterly net income of SUPN is $22.50M

What is the all-time high quarterly net income for Supernus Pharmaceuticals, Inc.?

Supernus Pharmaceuticals, Inc. all-time high quarterly net profit is $81.97M

What is Supernus Pharmaceuticals, Inc. quarterly net income year-on-year change?

Over the past year, SUPN quarterly net profit has changed by +$2.58M (+12.97%)

What is Supernus Pharmaceuticals, Inc. TTM net profit?

The current TTM net income of SUPN is $64.50M

What is the all-time high TTM net income for Supernus Pharmaceuticals, Inc.?

Supernus Pharmaceuticals, Inc. all-time high TTM net profit is $129.31M

What is Supernus Pharmaceuticals, Inc. TTM net income year-on-year change?

Over the past year, SUPN TTM net profit has changed by +$59.26M (+1131.09%)
On this page